StocksFin Logo
SRPT logo
$SRPT

Sarepta Therapeutics, Inc.

SRPT country of incorporation
|
https://www.sarepta.com
|
Mr. Douglas Ingram
|
840 employees
NASDAQ | Healthcare | Biotechnology
SRPT reported its Q322 earnings on November 2, 2022 (98 weeks ago).
$230.27M 21.6% vs. Q321 Revenues Q322
82.65% -5.7% vs. Q321 Gross Profit Margin
-111.93% ! -340.3% vs. Q321 Net Profit Margin
-73.2M ! 45.2% vs. Q321 Free Cash Flow Q322
$-2.94 ! -390% vs. Q321 EPS Q322
Company Card Q322
As reported on November 2, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 2, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
230.27M
-1.4%
39.95M
-257.74M
-11.3%
$-2.94
Q22022
233.49M
+10.7%
37.8M
-231.48M
-120.4%
$-2.65
Q12022
210.83M
31.44M
-105.03M
$-1.2
FY2021
701.89M
 97.05M
-418.78M
$-5.15
Q42021
201.46M
+6.4%
31.74M
-121.98M
-153.4%
$-1.53
Q32021
189.41M
+15.4%
23.44M
-48.14M
+40.9%
$-0.6
Q22021
164.09M
+11.7%
19.52M
-81.41M
+51.3%
$-1.02
Q12021
146.93M
22.35M
-167.25M
$-2.1
FY2020
540.1M
 63.38M
-554.13M
$-7.11
FY2019
380.83M
 56.59M
-715.08M
$-9.71
FY2018
301.03M
 34.19M
-361.92M
$-5.46
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
3.16B
 2.73B
1.04B
1.58B
430.84M
Q22022
3B
 2.27B
868.57M
1.14B
726.46M
Q12022
3.06B
 2.2B
1.23B
1.14B
856.89M
FY2021
3.15B
 2.22B
2.12B
1.14B
928.01M
FY2020
2.98B
 2.22B
1.5B
1.15B
761.76M
FY2019
1.82B
 1B
835.08M
681.9M
818.19M
FY2018
1.64B
 609.8M
370.83M
420.55M
1.03B
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-64.96M
 19.12M
216.43M
-8.23M
-73.2M
+3.6%
Q22022
-66.82M
 -289.99M
339k
-9.08M
-75.89M
+28.9%
Q12022
-101.18M
 -785.81M
4.99M
-5.55M
-106.73M
FY2021
-443.17M
 495.41M
561.57M
-38.49M
-481.66M
FY2020
107.47M
 -121.72M
682.32M
-82.2M
25.26M
FY2019
-456.46M
 286.73M
642.55M
-62.71M
-519.18M
FY2018
-388.66M
 -370.49M
530.15M
-64.35M
-453.01M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees